technology
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
arstechnica.com • 06 Aug 2026, 16:31
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Les originalartikkelen
Relaterte artikler etter nøkkelord
ages
- ChatGPT Can Take Over Your iMessages. But Do You Really Want That?
- Why Artemis Lunar Science Will Transform Our Understanding of the Moon
- Is Microsoft Copilot Worth Using on Windows 11? Key Features and Benefits Explained
- ChatGPT wants Full Disk Access to your Mac and Messages
- New ‘Slack Code’ turns AI coding into a team activity